Copyright
©2014 Baishideng Publishing Group Co.
World J Diabetes. Apr 15, 2014; 5(2): 165-175
Published online Apr 15, 2014. doi: 10.4239/wjd.v5.i2.165
Published online Apr 15, 2014. doi: 10.4239/wjd.v5.i2.165
Table 1 Clinical categorisation of hypertriglyceridaemia according to guidelines based on fasting triglyceride concentrations
Ref. | Yearpublished | Triglyceride categories | Triglyceride concentration (mmol/L) |
National institutes of Health[31] | 2001 | Normal | 1.7 |
Borderline high | 1.7-2.3 | ||
High | 2.3-5.6 | ||
Very high | > 5.6 | ||
Rydén et al[33] | 2011 | Desirable | < 1.7 |
Elevated | 1.7-5.5 | ||
Very high | 5.5-25.0 | ||
Extremely high | > 25.0 | ||
Berglund et al[34] | 2012 | Normal | < 1.7 |
Mild | 1.7-2.3 | ||
Moderately high | 2.3-11.2 | ||
Severely high | 11.2-22.4 | ||
Very severely high | > 22.4 | ||
Hegele et al[37] | 2013 | Normal | < 2.0 |
Mild-to-moderate | 2.0-10.0 | ||
Severe | > 10.0 |
- Citation: Pang J, Chan DC, Watts GF. Origin and therapy for hypertriglyceridaemia in type 2 diabetes. World J Diabetes 2014; 5(2): 165-175
- URL: https://www.wjgnet.com/1948-9358/full/v5/i2/165.htm
- DOI: https://dx.doi.org/10.4239/wjd.v5.i2.165